Randomized trial rationale outlines prednisolone therapy for unexplained recurrent pregnancy loss, indicating immune modulation may improve clinical pregnancy outcomes.
Unexplained recurrent pregnancy loss affects many fertile couples who want to conceive. Possibly, the maternal immune system is involved in the underlying mechanism of such unexplained cases and immune-suppressing corticosteroids can be used to modulate this system and improve pregnancy outcome. As a high quality, sufficiently powered randomized controlled trials in the unselected unexplained RPL population is currently lacking, the PREMI (Prednisolone administration in patients with unexplained REcurrent Miscarriages) trial was designed. Here, we discuss the rationale for the administration of prednisolone, including its potential mechanisms, safety, administration protocol and study population.
No takes yet. Share an insight, caveat, or question.
Lashley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: